• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Aetion Partners with Brigham and Women's Hospital and Harvard Medical School


Pharmaceutical Executive

Aetion, the software platform company, announced that Brigham and Women’s Hospital (BWH) and Harvard Medical School (HMS) chose the Aetion Evidence Platform to support their work on the REPEAT program.

The REPEAT program-Reproducible Evidence: Practices to Enhance and Achieve Transparency-focuses on quantifying the current state of transparency in health care database studies and developing guidance so that decision-makers are able to evaluate evidence from real-world data and drive better health care decisions. The platform distributes real-world analytics and evidence needed for biopharma and payers to engage in value-based care.


Related Videos
Related Content